Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
Submitted by
admin
on November 15, 2010 - 10:38am
Source:
Bloomberg
News Tags:
UCB Pharmaceuticals
M&A
Cimzia
Pfizer
rheumatoid arthritis
Headline:
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
Do Not Allow Advertisers to Use My Personal information
